Impurity issue stops Aurobindo irbesartan

A certificate of suitability (CEP) issued for bulk irbesartan made by Aurobindo Pharma in Hyderabad, India, has been suspended by the European Directorate for the Quality of Medicines (EDQM). Several other CEPs for irbesartan from other active pharmaceutical ingredient (API) suppliers remain in force.